X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-07 | AVTX | Sullivan Christopher Ryan | CFO | S - Sale+OE | $24.12 | -18,606 | 423 | -98% | -$448,818 | |||||
| D | 2026-05-06 | AVTX | Varki Paul | GC | S - Sale+OE | $20.17 | -75,063 | 3,634 | -95% | -$1,513,673 | |||||
| D | 2026-05-06 | AVTX | Sullivan Christopher Ryan | CFO | S - Sale+OE | $20.19 | -47,000 | 423 | -99% | -$948,722 | |||||
| DM | 2026-05-05 | AVTX | Doyle Mittie | Chief Medical Officer | S - Sale+OE | $20.61 | -108,234 | 3,622 | -97% | -$2,230,367 | |||||
2026-05-06 | AVTX | Chan Mitchell | Dir | S - Sale | $22.88 | -3,167 | 3,166 | -50% | -$72,461 | ||||||
| M | 2026-04-29 | AVTX | Sullivan Christopher Ryan | CFO | S - Sale | $13.16 | -16,915 | 423 | -98% | -$222,589 | |||||
| D | 2026-04-06 | AVTX | Doyle Mittie | Chief Medical Officer | S - Sale+OE | $18.01 | -3,970 | 3,622 | -52% | -$71,508 | |||||
| M | 2026-04-01 | AVTX | Sullivan Christopher Ryan | CFO | S - Sale | $16.96 | -15,959 | 17,338 | -48% | -$270,593 | |||||
| D | 2026-04-01 | AVTX | Doyle Mittie | Chief Medical Officer | S - Sale+OE | $16.00 | -679 | 3,622 | -16% | -$10,864 | |||||
| D | 2026-03-16 | AVTX | Doyle Mittie | Chief Medical Officer | S - Sale+OE | $16.15 | -25,492 | 3,622 | -88% | -$411,607 | |||||
| D | 2025-11-14 | AVTX | Goldman Jonathan | Dir | S - Sale+OE | $14.33 | -11,367 | 0 | -100% | -$162,937 | |||||
| M | 2024-11-12 | AVTX | Almenoff June Sherie | Dir | P - Purchase | $12.75 | +1,000 | 1,000 | New | +$12,750 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |